ISSN:
1573-7330
Keywords:
GnRH-agonist
;
polycystic ovary disease
;
hyperandrogenism
;
anovulation
;
episodic gonadotropin release
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Purpose: The fertility rate in women with polycystic ovarydisease (PCOD) is influenced by the type of treatmentreceived. The present study evaluated the possiblecorrelation between treatment and pulsatile release ofgonadotropins. Methods: Spontaneous episodic secretion of luteinizinghormone (LH) and follicle-stimulating hormone (FSH) andhormonal parameters were monitored before and after 1, 3, and6 months after treatments suspension. Twenty-four PCODpatients were randomnly divided into two groups of 12subjects. Group A was treated with gonadotropin-releasinghormone (GnRH)-analogue plus oral contraceptive (OC).Group B was treated only with OC. Both groups were treatedfor 6 months and followed up for 6 months. Results: In all subjects the therapeutic regimens reducedthe androgenic milieau and the gonadotropin plasma levels.Spontaneous pulsatile secretion of LH and FSH wassignificantly modified in both groups, but patients who receivedthe combined regimen showed a significantly greaterreduction of LH plasma levels and a significantly greater decreaseof LH pulse amplitude throughout the 6 months aftertreatment suspension. Ferriman=nGallway score and ovarianvolumes were significantly reduced in patients who receivedthe combined treatment than in the OC-treated patients. Conclusions: These data support the evidence of a higherefficacy of the combination of GnRH-a + OC than OC alonein restoring a normal and adequate spontaneous episodicgonadotropin discharge and in decreasingFerriman—Gallway score and ovarian volumes in patients with PCOD.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1023/A:1009410416638
Permalink
